PHAXIAM Therapeutics Ownership | Who Owns PHAXIAM Therapeutics?

PHAXIAM Therapeutics Ownership Summary

PHAXIAM Therapeutics is owned by 0.44% institutional investors, and 99.56% retail investors. Fidelity® NASDAQ Composite Index® is the top mutual fund, with 0.00% of its assets in PHAXIAM Therapeutics shares.

ERYP Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	PHAXIAM Therapeutics	0.44%	-	99.56%
Sector	Healthcare Stocks	47.06%	8.01%	44.93%
Industry	Biotech Stocks	44.97%	7.82%	47.21%

Institutional Shareholders

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2023	10	-9.09%	135,763	-63.64%	-	30.20%	3	-	2	-50.00%
Mar 31, 2023	11	10.00%	373,376	-50.29%	1	20.53%	3	-25.00%	4	100.00%
Dec 31, 2022	10	11.11%	751,045	-49.43%	2	10.56%	4	33.33%	2	-50.00%
Sep 30, 2022	9	12.50%	1,485,082	-1.24%	4	20.37%	3	-25.00%	4	100.00%
Jun 30, 2022	8	14.29%	1,503,746	-55.14%	4	4.15%	4	300.00%	2	-50.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity® NASDAQ Composite Index®	2.54K	0.00%	-

ERYP Ownership FAQ

Who Owns PHAXIAM Therapeutics?

PHAXIAM Therapeutics shareholders are primarily institutional investors at 0.44%, followed by 0% insiders and 0% retail investors. The average institutional ownership in PHAXIAM Therapeutics's industry, Biotech Stocks , is 44.97%, which PHAXIAM Therapeutics falls below.

Does Blackrock own PHAXIAM Therapeutics?

BlackRock is not among the top 10 institutional shareholders of PHAXIAM Therapeutics.

Who is the top mutual fund holder of PHAXIAM Therapeutics shares?

Fidelity® NASDAQ Composite Index® is the top mutual fund holder of PHAXIAM Therapeutics shares, with 0.00% of its total shares outstanding invested in 2.54K PHAXIAM Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools